Bioactive Nanotherapeutic Ultrasound Contrast Agent for Concurrent Breast Cancer Ultrasound Imaging and Treatment
Advanced Healthcare Materials · 2024
DOI: 10.1002/adhm.202401436 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Junyue Fang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Y…. Hauptthemen laut MEDLINE: Contrast Media, Ultrasonography, Nanoparticles. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Guangzhou Bureau of Basic Science grant, 111 project, Medical Scientific Research Foundation of Guangdong Province of China.
Abstract (Originalsprache)
Contrast‐enhanced ultrasound (CEUS) plays a crucial role in cancer diagnosis. The use of ultrasound contrast agents (UCAs) is inevitable in CEUS. However, current applications of UCAs primarily focus on enhancing imaging quality of ultrasound contrast rather than serving as integrated platforms for both diagnosis and treatment in clinical settings. In this study, a novel UCA, termed NPs‐DPPA(C 3 F 8 ), is innovatively prepared using a combination of nanoprecipitation and ultrasound vibration methods. The DPPA lipid possesses inherent antiangiogenic and antitumor activities, and when combined with C 3 F 8 , it functions as a theranostic agent. Notably, the preparation of NPs‐DPPA(C 3 F 8 ) is straightforward, requiring only one hour from raw materials to the final product due to the use of a single material, DPPA. NPs‐DPPA(C 3 F 8 ) exhibits inherent antiangiogenic and biotherapeutic activities, effectively inhibiting triple‐negative breast cancer (TNBC) angiogenesis and reducing VEGFA expression both in vitro and in vivo. Clinically, NPs‐DPPA(C 3 F 8 ) enables simultaneous real‐time imaging, tumor assessment, and antitumor activity. Additionally, through ultrasound cavitation, NPs‐DPPA(C 3 F 8 ) can overcome the dense vascular walls to increase accumulation at the tumor site and facilitate internalization by tumor cells. The successful preparation of NPs‐DPPA(C 3 F 8 ) offers a novel approach for integrating clinical diagnosis and treatment of TNBC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, P. R. China.
- Guangzhou Key Laboratory of Medical Nanomaterials, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, P. R. China.
- Cellular and Molecular Diagnostics Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, P. R. China.
- Department of Dermatology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, P. R. China.
- Department of Ultrasound, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, P. R. China.
- Department of General Medicine, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, P. R. China.
ORCID-Profile: Junyue Fang, Phei Er Saw
Förderung
- Guangzhou Bureau of Basic Science grant
- 111 project
- Medical Scientific Research Foundation of Guangdong Province of China
- Guangdong Basic and Applied Basic Research Foundation
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province of China
- Guangzhou Municipal Science and Technology Bureau
- Guangdong Provincial Fund for Distinguished Young Scholars
Zitieren
APA
Fang, J., Tan, J., Lin, L., Cao, Y., Xu, R., Lin, C., He, G., Xu, X., Xiao, X., Jiang, Q., & Saw, P. E. (2024). Bioactive Nanotherapeutic Ultrasound Contrast Agent for Concurrent Breast Cancer Ultrasound Imaging and Treatment. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202401436
Vancouver
Fang J, Tan J, Lin L, Cao Y, Xu R, Lin C, et al. Bioactive Nanotherapeutic Ultrasound Contrast Agent for Concurrent Breast Cancer Ultrasound Imaging and Treatment. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202401436
BibTeX
@article{Fang2024,
author = {Fang, Junyue and Tan, Jiabao and Lin, Li and Cao, Yuan and Xu, Rui and Lin, Chunhao and He, Gui and Xu, Xiaoding and Xiao, Xiaoyun and Jiang, Qiongchao and Saw, Phei Er},
title = {Bioactive Nanotherapeutic Ultrasound Contrast Agent for Concurrent Breast Cancer Ultrasound Imaging and Treatment},
journal = {Advanced Healthcare Materials},
year = {2024},
doi = {10.1002/adhm.202401436}
}
EUVIMED